341 participants
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2022-08-03
- Completion:
- 2026-07-06
Conditions
- Carcinoma
- Non-Small-Cell Lung
Interventions
- DRUG
No Results Yet